How Often to Get Ozempic Shots for Best Results

Last reviewed: July 2, 2026

Last updated: July 2, 2026

Written by: Jay Hastings, CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — science-backed guidance on GLP-1 medications, metabolic health, and precision weight management.

Semaglutide is a glucagon-like peptide-1 receptor agonist that reduces hunger signals and slows stomach emptying, helping patients lose an average of 15-22% of body weight over 68 weeks. The standard dosing schedule is one injection per week, though your specific dose may increase over time based on your response and tolerance. Understanding the correct injection frequency and how your dose may evolve helps you plan realistic timelines and stay committed to your weight loss journey.

The Standard Weekly Injection Schedule for Semaglutide

Semaglutide injections are administered once every seven days, typically on the same day each week for consistency and easier tracking. This weekly frequency allows the medication to build steady levels in your bloodstream, creating sustained appetite suppression throughout the week. Most patients choose a convenient day—such as Sunday morning or Wednesday evening—and set a phone reminder to maintain the routine.

The initial dose is usually 0.25 milligrams per week, introduced during a four-week starting phase. Your healthcare provider may increase your dose every four weeks in 0.25-milligram increments, moving toward a standard maintenance dose of 1 milligram weekly. Some patients benefit from higher doses up to 2.4 milligrams weekly, depending on weight loss goals, tolerance, and individual metabolic factors.

How Dose Escalation Works Over Time

Dose escalation typically follows a gradual titration schedule designed to minimize side effects like nausea while maximizing weight loss benefits. During weeks one through four, patients inject 0.25 milligrams weekly. Weeks five through eight increase to 0.5 milligrams weekly, with further increases occurring every four weeks until reaching an effective maintenance level.

The pace of dose increases is individualized—some patients reach their target dose in 12 weeks, while others take 16 weeks or longer. Your response to the medication, any side effects you experience, and your weight loss progress all influence whether your provider recommends moving to the next dose level. PlexusDx supports flexible dosing protocols, and importantly, your dose may increase, but your monthly price stays flat at $189, meaning you never pay the same monthly price at every dose level.

Optimal Injection Timing and Storage Considerations

Timing your injection at the same day and time each week helps your body maintain consistent medication levels and simplifies adherence. Many patients inject on Sunday morning, pairing the ritual with their weekly routine of meal planning or grocery shopping. The specific time of day matters less than consistency, so choose whatever works best for your lifestyle.

Semaglutide pens or vials must be stored in the refrigerator at 36–46 degrees Fahrenheit before first use. Once opened, they may be kept at room temperature (below 86 degrees Fahrenheit) for up to 28 days. Storing your pen in a dedicated medication container or on a specific refrigerator shelf prevents accidental damage and keeps it visible as a weekly reminder.

Personalized Dosing With PlexusDx Precision Peptide Testing

Individual genetic variations affect how efficiently your body responds to semaglutide and other GLP-1 medications. The PlexusDx Precision Peptide Genetic Test identifies key variants in genes like GIPR (rs1800437), FTO (rs9939609), and MC4R (rs17782313) that influence peptide signaling and weight loss capacity. This $298 test performed after your first month of treatment maps 14 metabolic pathways, 49 peptides, and 150+ genetic insights to optimize your personalized protocol.

Patients with certain GLP1R variants may experience stronger appetite suppression at lower doses, while those with specific FTO variants might benefit from gradual dose escalation. Understanding your genetic peptide profile helps your PlexusDx provider recommend whether you're a candidate for once-weekly semaglutide alone, or whether adding a complementary medication like tirzepatide (GLP-Squared Injection) offers better results. This precision approach shortens the trial-and-error phase and accelerates your path to your target dose.

Maintaining Results: Long-Term Injection Frequency

Once you reach your target dose, you continue injecting once weekly indefinitely to maintain your weight loss results. Clinical data shows that weight regain occurs if patients stop taking semaglutide, so weekly injections become part of ongoing weight management. Many long-term users describe the weekly injection as simple habit—comparable to taking a daily medication—once they've established their routine.

PlexusDx serves all 50 states with no insurance required and no membership fees, ensuring continuous access to your semaglutide therapy at $189/mo month-to-month, or from $149/mo on the 6-month plan on flat pricing. Your medication comes from licensed 503A compounding pharmacies, and HSA and FSA accounts are eligible for payment. Regular check-ins with your PlexusDx provider help track your progress, confirm your dose is optimal, and adjust your regimen if needed.

How Your Genetics Relate to GLP-1 Pathways

Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, FTO rs9939609, and MC4R rs17782313 — relate to the biological pathways these medications act on. These are pathway-level associations only and do not predict how much weight you will lose or how you will respond to any specific medication. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights so you and your provider can see how your genes relate to these pathways. It does not recommend, prescribe, or determine which medication, dose, or peptide is right for you. The PlexusDx Precision Peptide Genetic Test ($298) gives you and your provider pathway-level genetic context to support a more personalized conversation. Genetics is a guide, not a guarantee.

Access Personalized GLP-1 Care Through PlexusDx

PlexusDx offers seven prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Semaglutide Injection is $189/mo month-to-month, or from $149/mo on the 6-month plan. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $298 to personalize your protocol from day one.

Frequently Asked Questions

Can I miss a weekly semaglutide injection and double up the following week?

No. If you miss an injection by one or two days, take it as soon as you remember and resume your regular schedule the following week. If you miss your injection by more than two days, wait and take your next scheduled dose on your regular day. Never double-dose to make up for a missed injection, as this may cause nausea or other side effects.

What does the clinical evidence show about once-weekly semaglutide dosing?

Landmark trials including STEP 1, STEP 2, and STEP 3 demonstrated that once-weekly semaglutide at 2.4 milligrams produces average weight loss of 15-22% of baseline body weight over 68 weeks. Once-weekly dosing is effective because semaglutide has a long half-life of approximately seven days, allowing sustained receptor activation throughout the week.

Does PlexusDx adjust pricing if my dose increases during treatment?

No. PlexusDx compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan) on flat pricing across all dose levels. Your dose may increase from 0.25 to 2.4 milligrams or higher, but your monthly cost remains $149, meaning you never pay the same monthly price at every dose level.

What if I experience significant nausea on my current semaglutide dose?

Nausea is a common early side effect that often improves within days or weeks as your body adjusts. If nausea persists or is severe, contact your PlexusDx provider—they may recommend delaying your next dose increase, suggesting anti-nausea strategies, or exploring alternative medications. Most patients experience nausea that resolves without stopping treatment.

How does the PlexusDx Precision Peptide Genetic Test improve my dosing plan?

No — the Precision Peptide Genetic Test does not predict your response to semaglutide or any specific medication. It analyzes pathway-level variants (GIPR, FTO, and MC4R) that relate to the biology involved, offering context for a conversation with your provider rather than a prediction.

Related Reading

• Lifemd Ozempic
• Eden Ozempic
• Ro Ozempic
• Mochi Ozempic

Pricing and availability current as of July 2026. Compounded GLP-1 medications are not FDA-approved drug products; they are prepared by licensed compounding pharmacies under federal compounding regulations. Compounded semaglutide and tirzepatide are not the same as Wegovy, Ozempic, Zepbound, or Mounjaro. This article is for informational purposes only and does not constitute medical advice. Consult a licensed healthcare provider before starting, stopping, or changing any medication.

Return to the PlexusDx Education Hub for more evidence-based resources on GLP-1 therapy, metabolic health, and personalized weight management.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.